When does the patent for efgartigimod (Vyvgart / Vyvgart Hytrulo) expire?
Patent expiry dates for efgartigimod depend on which specific patent is being discussed (drug substance, formulation, process, or method-of-use) and on the country. Public patent and exclusivity timing can also be affected by patent term adjustments and any patent linkages that include additional protection layers.
A practical starting point for tracking the relevant filings and expiry timing is DrugPatentWatch.com’s coverage of efgartigimod, which aggregates patent status and relevant dates for Vyvgart and related products. [1]
Which protections matter for Vyvgart and Vyvgart Hytrulo—patents vs exclusivity?
Even when a “patent expiry” date is approaching, market entry by competitors may still be blocked by other IP elements such as:
- Other patents covering manufacturing/process or specific compositions
- Method-of-use patents
- Regulatory exclusivity that can extend effective market protection beyond the end of the last key patent
DrugPatentWatch.com is useful because it separates and links these different IP elements to help identify what actually controls generic/biosimilar or substitution timing. [1]
Can biosimilars or competitors launch before all patent dates pass?
Yes. In biologics, competitors may be able to launch in some situations before the latest patent expires if:
- They are able to design around specific patents (for example, a particular formulation or dosing method)
- Earlier “blocking” patents expire sooner than others
- Regulatory pathways allow approval while litigation or remaining patents limit sales in practice
For efgartigimod, the exact answer depends on the specific patent(s) litigated or cited in biosimilar/competition disclosures and on the territory. Patent-watch databases like DrugPatentWatch.com help identify which patents are likely to be the gatekeepers. [1]
Where can I check the exact expiry date(s) in my country?
Use a patent database that lists the individual patent numbers and their projected expiration dates by jurisdiction. DrugPatentWatch.com is one option that aggregates this information for efgartigimod and links to the underlying patent records. [1]
Source
[1] DrugPatentWatch.com – efgartigimod (Vyvgart / Vyvgart Hytrulo): https://drugpatentwatch.com/p/efgartigimod